FDA Clears AI Tool for Detecting Low Ejection Fraction from ECGs
The software analyzes 12-lead ECGs to detect signs of low left ventricular ejection fraction in patients at risk of heart failure.
Read MoreJul 17, 2025 | Artificial Intelligence | 0 |
The software analyzes 12-lead ECGs to detect signs of low left ventricular ejection fraction in patients at risk of heart failure.
Read MoreMay 8, 2025 | Remote Monitoring | 0 |
Peerbridge Health’s AI-enabled Cor MDx wearable receives MedTech Breakthrough Award for advancing cardiac diagnostics and patient monitoring.
Read MoreJun 25, 2024 | Clearances | 0 |
AliveCor has launched the FDA-cleared KAI 12L AI technology and the Kardia 12L ECG System portable ECG solutions.
Read MoreAug 15, 2023 | Company News | 0 |
Clario announced an expansion to its collaboration with AliveCor, provider of FDA-cleared personal electrocardiogram (ECG) technology.
Read MoreJun 2, 2023 | Remote Monitoring | 0 |
This collaboration will combine the strengths of PaceMate’s cardiac remote monitoring platform with AliveCor’s KardiaPro platform.Â
Read More